|Appears in Collections:||Faculty of Health Sciences and Sport Journal Articles|
|Peer Review Status:||Refereed|
|Title:||Evaluation of a mobile phone based, Advanced Symptom Management System (ASyMS©) in the management of chemotherapy related toxicity|
McCann, Lisa Ann
mobile phone based technology
Cancer pain Treatment
Oncologic Nursing methods
Telecommunication in medicine
|Citation:||Kearney N, McCann LA, Norrie J, Taylor L, Gray P, McGee-Lennon M, Sage M, Miller M & Maguire R (2009) Evaluation of a mobile phone based, Advanced Symptom Management System (ASyMS©) in the management of chemotherapy related toxicity. Supportive Care in Cancer, 17 (4), pp. 437-444. https://doi.org/10.1007/s00520-008-0515-0|
|Abstract:||OBJECTIVES: To evaluate the impact of a mobile phone-based, remote monitoring, advanced symptom management system (ASyMS((c))) on the incidence, severity and distress of six chemotherapy-related symptoms (nausea, vomiting, fatigue, mucositis, hand-foot syndrome and diarrhoea) in patients with lung, breast or colorectal cancer. DESIGN: A two group (intervention and control) by five time points (baseline, pre-cycle 2, pre-cycle 3, pre-cycle 4 and pre-cycle 5) randomised controlled trial. SETTING: Seven clinical sites in the UK; five specialist cancer centres and two local district hospitals. PARTICIPANTS: One hundred and twelve people with breast, lung or colorectal cancer receiving outpatient chemotherapy. INTERVENTIONS: A mobile phone-based, remote monitoring, advanced symptom management system (ASyMS((c))). MAIN OUTCOME MEASURES: Chemotherapy-related morbidity of six common chemotherapy-related symptoms (nausea, vomiting, fatigue, mucositis, hand-foot syndrome and diarrhoea). RESULTS: There were significantly higher reports of fatigue in the control group compared to the intervention group (odds ratio = 2.29, 95%CI = 1.04 to 5.05, P = 0.040) and reports of hand-foot syndrome were on average lower in the control group (odds ratio control/intervention = 0.39, 95%CI = 0.17 to 0.92, P = 0.031). CONCLUSION: The study demonstrates that ASyMS((c)) can support the management of symptoms in patients with lung, breast and colorectal cancer receiving chemotherapy.|
|Rights:||Published in Supportive Care In Cancer by Springer-Verlag. The original publication is available at www.springerlink.com|
|ASyMS Final Complete version in press.pdf||Fulltext - Accepted Version||303.42 kB||Adobe PDF||View/Open|
This item is protected by original copyright
Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.
The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/
If you believe that any material held in STORRE infringes copyright, please contact email@example.com providing details and we will remove the Work from public display in STORRE and investigate your claim.